🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Marketa Janatova

Charles University

ORCID: 0000-0003-2816-6769

Also affiliated with General University Hospital in Prague

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “ENIGMA CHEK2 gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk”.

ENIGMA CHEK2 gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0212

N/A

0.520DataRank · unranked

31 citations

Petra Kleiblova, Petra Zemánková, Barbora Šťastná, Marketa Janatova, Jana Soukupová +95 more

Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer

The Breast(2025)10.1016/j.breast.2025.104619

N/A

0.104DataRank · unranked

1 citations

Gisella Figlioli, Clémence Mooser, Irene Casamassima, Violette Azzoni, Jahnavi Srivatsa +95 more

Site-saturation functional screens identify PALB2 missense variants associated with increased breast cancer risk

Nature Communications(2026)10.1038/s41467-025-67252-z

N/A

0DataRank · unranked

0 citations

Sabine C. Knaup, Roberta Menafra, Merel E. Braspenning, Magdalena B. Rother, Petra Kleiblova +78 more